logoTry Persana

1910 Genetics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about 1910 Genetics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

1910 Genetics company logo

Advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.

1910 Genetics is a biotechnology company focused on accelerating small and large molecule drug discovery through a multimodal AI platform powered by laboratory automation.

HeadquartersBoston, United States
Team size10-50
Founded2018

What is 1910 Genetics? - Company Overview & Details

1910 Genetics is 1910 Genetics is a biotechnology company focused on accelerating small and large molecule drug discovery through a multimodal AI platform powered by laboratory automation. Founded in 2018, the company is headquartered in Boston, United States.

Who Founded 1910 Genetics?

1910 Genetics was founded by Jen Nwankwo.

Who are the Key Executives at 1910 Genetics? - Leadership Team

1910 Genetics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of 1910 Genetics

Jen NwankwoCEO

About Jen Nwankwo - CEO of 1910 Genetics

Jen Nwankwo serves as the Chief Executive Officer of 1910 Genetics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

1910 Genetics Company Details & Key Information

Where is 1910 Genetics located?

1910 Genetics is headquartered in Boston, United States.

How many employees does 1910 Genetics have?

1910 Genetics has 10-50 employees.

When was 1910 Genetics founded?

1910 Genetics was founded in 2018.

1910 Genetics Official Website

How much funding has 1910 Genetics raised?

1910 Genetics has raised $26.1 Million across 9 funding rounds. The most recent funding was completed on 2024-12-01.

Funding Overview

1910 Genetics has raised a total of $26.1 million to support its AI-driven drug discovery efforts, including a recent funding round from Accenture Ventures.

$26.1 Million
Total Funding Raised
9
Funding Rounds
2024-12-01
Latest Round

1910 Genetics Funding History

Grant
2021-10-30
$550,000
Series unknown
2024-12-01

Who are the key investors in 1910 Genetics?

1910 Genetics is backed by 5 key investors including M12 - Microsoft's Venture Fund, Playground Global, Sam Altman. These investors focus on Healthcare, Biotechnology, AI sectors.

1910 Genetics Investor Overview

5
Key Investors
6
Focus Areas
5
Notable Investments

Complete List of 1910 Genetics Investors

M12 - Microsoft's Venture Fund

Investment Focus
Healthcare
Biotechnology
AI
Notable Portfolio Companies
1910 Genetics

Playground Global

Investment Focus
Technology
Healthcare
Notable Portfolio Companies
1910 Genetics

Sam Altman

CEO of OpenAI and prominent tech investor.

Investment Focus
AI
Tech Startups
Notable Portfolio Companies
1910 Genetics

FoundersX Ventures

Notable Portfolio Companies
1910 Genetics

Scientia Ventures

Notable Portfolio Companies
1910 Genetics

What sectors do 1910 Genetics investors focus on?

The investors backing 1910 Genetics primarily focus on Healthcare, Biotechnology, AI, Technology, Tech Startups, sectors.

Healthcare
Biotechnology
AI
Technology
Tech Startups

Featured Investor: M12 - Microsoft's Venture Fund

M12 - Microsoft's Venture Fund

Notable Investments: 1910 Genetics

What are 1910 Genetics's future plans?

1910 Genetics 1910 Genetics aims to leverage its advanced AI technology to enhance drug discovery efficiency and overcome challenges in drug development.

1910 Genetics Strategic Outlook

Strategic Focus
Defined
0
Key Challenges
2
Growth Opportunities

What opportunities does 1910 Genetics have?

1910 Genetics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for 1910 Genetics

1

Expanding partnerships with pharmaceutical companies

2

Enhancing AI capabilities for drug design

1910 Genetics Strategic Position Summary

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about 1910 Genetics?

1910 Genetics has 2 recent news updates covering key business developments and market activities.

1910 Genetics News Overview

2
Recent Articles
Active
Media Coverage
2024-10-25
Latest Update

What is 1910 Genetics in the news for?

1910 Genetics is currently featured in news for 1910 Genetics, Inc. launches advanced AI model for blood-brain barrier drug permeability. and other significant business developments.

Recent News Articles About 1910 Genetics

Article 1
2024-10-25

1910 Genetics, Inc. launches advanced AI model for blood-brain barrier drug permeability.

1910 Genetics has launched CANDID-CNS, an AI model designed to improve drug permeability through the blood-brain barrier.

fmai-hub.com
Read News
Article 2
2024-10-17

1910 Genetics, Inc. launches CANDID-CNS.

1910 Genetics launches CANDID-CNS, an AI model for predicting blood-brain barrier permeability that outperforms industry standards.

1910genetics.com
Read News

1910 Genetics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about 1910 Genetics including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

1910 Genetics Questions & Answers - Company Information

Q1

What is 1910 Genetics?

1910 Genetics is a biotechnology company focused on accelerating small and large molecule drug discovery through a multimodal AI platform powered by laboratory automation.

Q2

Who founded 1910 Genetics?

1910 Genetics was founded by Jen Nwankwo.

Q3

Who is the CEO of 1910 Genetics?

The CEO of 1910 Genetics is Jen Nwankwo. You can find more information about them on their LinkedIn profile.

Q4

How much funding has 1910 Genetics raised?

1910 Genetics has raised a total of $$26.1 Million across 9 funding rounds. The most recent funding was completed on 2024-12-01.

Q5

Who are the investors in 1910 Genetics?

1910 Genetics's key investors include M12 - Microsoft's Venture Fund, Playground Global, Sam Altman, FoundersX Ventures, Scientia Ventures.

Q6

Where is 1910 Genetics headquartered?

1910 Genetics is headquartered in Boston, United States.

Q7

When was 1910 Genetics founded?

1910 Genetics was founded in 2018.

Q8

How many employees does 1910 Genetics have?

1910 Genetics has 10-50 employees.

Q9

What is 1910 Genetics's official website?

You can visit 1910 Genetics's official website at https://1910genetics.com.

Q10

What was 1910 Genetics's latest funding round?

1910 Genetics's latest funding round was a Grant round of $$550,000 completed on 2021-10-30.

Q11

Who is founder?

Jen Nwankwo

Q12

What does the company do?

1910 Genetics specializes in drug discovery using an AI platform that integrates machine learning with laboratory automation.

Q13

How much funding?

$26.1 Million

Q14

Latest funding date?

2024-12-01

Q15

Who are the investors?

M12 - Microsoft's Venture Fund Playground Global Sam Altman FoundersX Ventures Scientia Ventures

Q16

What are the opportunities?

Expanding partnerships with pharmaceutical companies Enhancing AI capabilities for drug design

Q17

Latest news?

1910 Genetics has launched CANDID-CNS, an AI model designed to improve drug permeability through the blood-brain barrier. 1910 Genetics launches CANDID-CNS, an AI model for predicting blood-brain barrier permeability that outperforms industry standards.

More Information About 1910 Genetics

For additional details about 1910 Genetics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.